Singapore Oncology Drugs Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : February 2022
  • Region: Singapore
  • Country: Other
  • Report ID : 5074

  • Format: PPT, PDF

Singapore Oncology Drugs Market: Segmented by Therapy Modality Type and Cancer Type, and End User Type- Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2028

Clear
SKU: 5074 Categories: ,

Report Description of the Singapore Oncology Drugs Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of Singapore Oncology Drugs Drugs market
  • To classify and forecast Singapore Oncology Drugs Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for Singapore Oncology Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Singapore Oncology Drugs market
  • To conduct pricing analysis for Singapore Oncology Drugs Drugs market
  • To identify and analyze the profile of leading players operating in Singapore Oncology Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Singapore Oncology Drugs Market Executive Summary

In Singapore cancer cases have been rising over the years, and the number of people living with cancer will continue to increase. During the period from 2014-2018, 74,536 cancer cases were reported in Singapore and 48.5% and 51.5% of those cases were reported in males and females respectively. Thus growing the incedence of cancer cases is likely to drive the growth of the Singapore oncology drugs market.

Market Size and Key Findings

The Singapore Oncology Drugs market size is at around USD xx billion in 2021 and is projected to reach USD xx billion in 2028, exhibiting a CAGR of xx% during the forecast period.

In 2019 cancer accounts for 28.4% of all deaths in Singapore. The number of cancer cases increased nearly 6 times from 12,072 in 1968-1972 to 71,265 in 2013-2017.This meant that an average of 14,253 cancer diagnoses are reported every year, equating to around 39 Singaporeans being diagnosed with cancer every single day.Consequently these factors  likely to drive the growth of the Oncology market in Singapore during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Major factors driving the Singapore oncology drugs market are rising Prevalence of Cancer, growing government Initiatives for cancer awareness, increasing patient assistance programs (PAPs). Furthermore, increase in R&D and the rising prevalence of various types of cancer across the globe.

Market Restraints

High cost of cancer therapies and fluctuation in reimbursement policies are the factors affecting the Singapore oncology drugs market negatively.

Competitive Landscape

Key Players

Key market players in Singapore Oncology Drugs market include Abbvie, Amgen, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, Eli Lilly, Johnson & Johnson, Hoffmann-La Roche Ltd, Sanofi and Others

Products in Pipeline

May 19, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnsonannounced new data from the fixed-duration cohort of the investigational Phase 2 CAPTIVATE study, showing that 95 percent of patients treated with combined IMBRUVICA® plus venetoclax were alive and progression-free at two years. Deep remissions were seen across all subgroups, including patients with high-risk chronic lymphocytic leukemia (CLL). In addition, long-term data from the RESONATE-2 (PCYC-1115/1116) study will be presented, providing the longest follow-up Phase 3 data for any BTK inhibitor to date. These data reinforce the long-term survival benefits and well-established safety profile of single-agent IMBRUVICA® for patients with CLL.

Notable Recent Deals

July 27, 2021 — Amgen (NASDAQ: AMGN) and Teneobio announced an agreement under which Amgen will acquire Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called Human Heavy-Chain Antibodies.  Under the terms of the agreement, Amgen will acquire all outstanding shares of Teneobio at closing in exchange for a $900 million upfront cash payment, as well as future contingent milestone payments to Teneobio equity holders potentially worth up to an additional $1.6 billion in cash.

The acquisition will also add TNB-585, a Phase 1 bispecific T cell-engager for the treatment of metastatic castrate-resistant prostate cancer (mCRPC), and several preclinical oncology pipeline assets with the potential for near-term IND filings.  TNB-585 complements Amgen’s existing prostate cancer portfolio, which includes acapatamab (formerly AMG 160) and AMG 509, both in Phase 1.  Each of these three investigational therapies uses a different approach to treat a highly prevalent disease for which new treatment options are very much needed.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of Singapore Oncology Drugs Services

The Government has accepted the MediShield Life Council’s recommendations to create a list of clinically proven and cost-effective outpatient cancer drug treatments, allow these cancer drug treatments to be claimable under MediShield Life, and set more granular claim limits to provide better coverage based on the cost of each treatment.

Subsidised patients in the public healthcare institutions currently receive up to 75% subsidy for drugs under the Standard Drug List (SDL) and MAF. Following price negotiations with drug manufacturers to achieve better drug prices and cost-effectiveness, 55 more cancer drugs will be listed under the SDL/MAF, which will increase support for around 150 cancer drug treatments. The new MediShield Life claim limits for cancer drug treatments will be set based on post-subsidy bills.

1. Report Description of the Singapore Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Singapore Oncology Drugs Market Executive Summary
2.1 Singapore Oncology Drugs Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Singapore Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.1.1 Rising Prevalence of Cancer
3.1.2 Growing Government Initiatives for Cancer Awareness
3.1.3 Increasing Patient Assistance Programs (PAPs)
3.2 Market Restraints Analysis
3.3 High Cost of Cancer Therapies
3.4 Fluctuation in Reimbursement Policies
4. Oncology Drugs Market Segmentation
4.1 By Therapy Modality Type Analysis:
4.1.1 Chemotherapy
4.1.2 Immunotherapy
4.1.3 Target Therapy
4.1.4 Hormonal Therapy
4.1.5 Other Treatment Type
4.2 By Cancer Type Analysis:
4.2.1 Blood Cancer
4.2.2 Breast Cancer
4.2.3 Prostrate Cancer
4.2.4 Gastrointestinal Cancer
4.2.5 Respiratory/Lung Cancer
4.2.6 Skin Cancer
4.2.7 Other Cancer Types
4.3 By End User Analysis:
4.3.1 Hospitals
4.3.2 Speciality Clinics
4.3.3 Radiation Therapy Centers
5. Singapore Oncology Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Singapore Oncology Drugs Market
6.4 Notable recent deals in Singapore Oncology Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Abbvie Company Overview
Product & Services, Strategies & Financials
7.2 Amgen Company Overview
Product & Services, Strategies & Financials
7.3 GlaxoSmithKline Company Overview
Product & Services, Strategies & Financials
7.4 Merck & Co. Company Overview
Product & Services, Strategies & Financials
7.5 Hoffmann-La Roche Ltd Company Overview
Product & Services, Strategies & Financials
7.6 Novartis Company Overview
Product & Services, Strategies & Financials
7.7 Pfizer Company Overview
Product & Services, Strategies & Financials
7.8 Eli Lilly Company Overview
Product & Services, Strategies & Financials
7.9 Johnson & Johnson Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of Singapore Oncology Drugs Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development Singapore Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations

Oncology Drugs Market Segmentation

By Therapy Modality Type:

Availability of various advance oncology treatment such as targeted therapy and hormonal therapy among others will enhance the segment expansion.

  • Chemotherapy
  • Immunotherapy
  • Target Therapy
  • Hormonal Therapy
  • Other Therapy Type

By Cancer Type:

The cancer segment is expected to rise exponentially during the forecast period. The growing prevalence of cancer and rising awareness regarding therapeutics will boost the segment’s growth.

  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Respiratory/Lung Cancer
  • Skin Cancers
  • Other Cancers

By End User Type:

Based on End User type the market is segmented into hospitals, speciality clinics and radiation therapy centers.

  • Hospitals
  • Speciality Clinics
  • Radiation Therapy Centers

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements